They show you whether your "tiny meals" are actually too low in protein, whether weekend intake is erasing weekday progress, or whether your calories are so low that you're dragging through the day
Everolimus plus exemestane for hormonereceptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Changes in eating patterns, blood sugar fluctuations during the night, and general metabolic adaptation can all affect sleep quality
Cost without insurance is approximately $1,000-1,200 per month for brand-name tirzepatide
Among emerging CKD-protective treatments, finerenone was approved by the FDA in 2021 and was also recommended in the 2022 KDIGO guidelines as first-line therapy for patients with type 2 diabetes who are at high risk of kidney disease progression and cardiovascular events [6, 15]